Compare VCYT & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCYT | LXP |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | N/A | 58 |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2013 | N/A |
| Metric | VCYT | LXP |
|---|---|---|
| Price | $32.95 | $47.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $45.13 | ★ $51.88 |
| AVG Volume (30 Days) | ★ 802.9K | 611.2K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.87% |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.33 | $1.71 |
| Revenue Next Year | $12.53 | $8.03 |
| P/E Ratio | $41.38 | ★ $26.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $6.85 |
| 52 Week High | $50.71 | $52.52 |
| Indicator | VCYT | LXP |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 41.13 |
| Support Level | $32.51 | $47.35 |
| Resistance Level | $32.79 | $51.06 |
| Average True Range (ATR) | 1.45 | 1.20 |
| MACD | -0.16 | -0.16 |
| Stochastic Oscillator | 0.42 | 32.91 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.